Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Strong, R., Miller, R. A., Cheng, C. J., Nelson, J. F., Gelfond, J., Allani, S. K., Diaz, V., Dorigatti, A. O., Dorigatti, J., Fernandez, E., Galecki, A., Ginsburg, B., Hamilton, K. L., Javors, M. A., Kornfeld, K., Kaeberlein, M., Kumar, S., Lombard, D. B., Lopez‐Cruzan, M., … Harrison, D. E. (2022). Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice. Aging Cell, 21(12). Portico. https://doi.org/10.1111/acel.13724
Authors:
Randy Strong
Richard A Miller
Catherine J Cheng
James F Nelson
Jonathan Gelfond
Shailaja Kesaraju Allani
Vivian Diaz
Angela Olsen Dorigatti
Jonathan Dorigatti
Elizabeth Fernandez
Andrzej Galecki
Brett Ginsburg
Karyn L Hamilton
Martin A Javors
Kerry Kornfeld
Matt Kaeberlein
Suja Kumar
David B Lombard
Marisa Lopez-Cruzan
Benjamin F Miller
Peter Rabinovitch
Peter Reifsnyder
Nadia A Rosenthal
Molly A Bogue
Adam B Salmon
Yousin Suh
Eric Verdin
Herbert Weissbach
John Newman
Francesca Maccchiarini
David E Harrison
Affiliated Authors:
Yousin Suh
Columbia Affiliation:
Subjects:
Acarbose (MeSH)
Sirolimus (MeSH)
Author Keywords:
acarbose plus rapamycin
captopril
survival
elink
Publication Type:
Article
Unique ID:
10.1111/acel.13724
PMID:
36179270
DOI:
10.1111/acel.13724
Journal:
Aging Cell
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: